New Medications in the Treatment of Acute Decompensated Heart Failure

Acute decompensated heart failure is a sudden worsening of heart failure symptoms, typically resulting in peripheral edema and dyspnea as a result of pulmonary congestion. Acute decompensated heart failure is responsible for over 1 million hospitalizations every year. Current pharmacologic therapy is limited in its options. Despite an improved survival rate, statistic still suggests that about 50% of patients die within 5 years of diagnosis. New pharmacologic agents aim to improve efficacy by targeting previously unexplored physiological pathways. (The full article is available in the March issue of Hospital Pharmacy) 

​You can track these drugs and others in the Prescribe Right Pharmaceutical Pipeline Tracker